Regencell Bioscience(US:RGC) Ge Long Hui·2026-01-08 09:35Group 1 - The core viewpoint of the news is that Neural Regeneration Technology (RGC.US) has seen a significant stock price increase, rising 16.3% in pre-market trading and a total of 157% over the past three days, driven by Elon Musk's recent production forecast, which has catalyzed a surge in the brain-computer interface sector [1] - RGC's relationship with brain-computer interfaces can be understood as an upstream and downstream connection in medicine, where "repairing hardware" relates to "establishing connections" [1] - According to a report from Changjiang Securities, the brain-computer interface industry in China is experiencing rapid advancements, and with policy support, it is expected to enter a period of development opportunities, accelerating the transition from industrial research to commercialization [1] Group 2 - As of January 7, the closing price of RGC was $52.880, reflecting a 60.10% increase, while the pre-market price on January 8 was $61.500, up 16.30% [2] - The stock has shown significant volatility, with a trading range of 59.37% and a turnover rate of 17.48% [2] - The total market capitalization of RGC is approximately $26.149 billion, with a total share count of 494 million [2]